Titlebook: Venture Capital and the European Biotechnology Industry; William Bains Book 2009 Palgrave Macmillan, a division of Macmillan Publishers Li

强烈的愿望

书目名称Venture Capital and the European Biotechnology Industry影响因子(影响力)




书目名称Venture Capital and the European Biotechnology Industry影响因子(影响力)学科排名




书目名称Venture Capital and the European Biotechnology Industry网络公开度




书目名称Venture Capital and the European Biotechnology Industry网络公开度学科排名




书目名称Venture Capital and the European Biotechnology Industry被引频次




书目名称Venture Capital and the European Biotechnology Industry被引频次学科排名




书目名称Venture Capital and the European Biotechnology Industry年度引用




书目名称Venture Capital and the European Biotechnology Industry年度引用学科排名




书目名称Venture Capital and the European Biotechnology Industry读者反馈




书目名称Venture Capital and the European Biotechnology Industry读者反馈学科排名

Cacophonous

Why Does Europe Do So Poorly? Some Inadequate Explanations, think is the main reason — the business practices of the VC groups that control the industry — it is worthwhile discussing the ‘reasons’ that are usually given, and showing why they are at most a minor cause of the relative lack of growth and frequent commercial and financial failure of the Europea

和音

Public Markets and Underinvestment,stantial profit on their investment. The sections above show (in rather tedious detail) that it does not do so, and that the ‘gap’ in finance in Europe is in fact a reflection of this. I have argued that this is not because companies are not there to invest in, nor that the science, management, entr

孵卵器

VC Effects on Business Efficacy,ge when it is counterproductive to the VC’s own goals of stock value appreciation and IPO. An explanation for this rather odd set of observations is that the VC has a deep knowledge of how a biotech business should be run and, while they do not have the time to provide that understanding to the comp

attenuate

Investor Blockade of Business,plausible claim, surely they would not go out of their way to sabotage an investee company? Of course they do not. But the effect of the way they invest is to achieve a similar goal. To explain this I will have to digress into a short discussion on share structures in VC-invested startup companies.

音的强弱

Pomp and Circumstance,t have thought that the VC/manager would at least want to conserve every penny of cash that the company had. However, the business model as it is pursued by VC-backed biotechnology companies in Europe does not appear to do this either. What I called ‘Cargo Cult Economics’ in Chapter 1 appears to app

Counteract

事先无准备

Why Does Europe Do So Poorly? Some Inadequate Explanations,ally given, and showing why they are at most a minor cause of the relative lack of growth and frequent commercial and financial failure of the European industry. In this section I will explicitly leave out financial reasons such as the structure of the capital markets — we will deal with this in Chapter 6.

补角

The Real VC Business Model,r influence is so all pervading and their role in the industry so crucial that they must be a significant factor in its failure, and we have identified some of the mechanisms through which this occurs.

Malaise

s fallen behind the US due to under-investment and bad management by the VCs who control the companies.  Detailed analysis shows why it is in VCs‘ interests to damage the very companies they invest in.978-1-349-30381-6978-0-230-22726-2